Literature DB >> 27697815

Adverse drug reactions.

Jamie J Coleman1, Sarah K Pontefract2.   

Abstract

Adverse drug reactions (ADRs) remain a challenge in modern healthcare, particularly given the increasing complexity of therapeutics, an ageing population and rising multimorbidity. This article summarises some of the key facts about ADRs and explores aspects relating to their prevention, diagnosis, reporting and management in current clinical practice. © Royal College of Physicians 2016. All rights reserved.

Keywords:  Adverse drug reactions; adverse drug reaction reporting systems; clinical pharmacology; drug-related side effects and adverse reactions; pharmacovigilance

Mesh：

Year:  2016        PMID： 27697815      PMCID： PMC6297296          DOI： 10.7861/clinmedicine.16-5-481

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN： 1470-2118            Impact factor:   2.659


  13 in total

Review 1.  Joining the DoTS: new approach to classifying adverse drug reactions.

Authors:  J K Aronson; R E Ferner
Journal:  BMJ       Date:  2003-11-22

Review 2.  Preventability of drug-related harms - part I: a systematic review.

Authors:  Robin E Ferner; Jeffrey K Aronson
Journal:  Drug Saf       Date:  2010-11-01       Impact factor: 5.606

Review 3.  Clarification of terminology in drug safety.

Authors:  Jeffrey K Aronson; Robin E Ferner
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 4.  Monitoring for adverse drug reactions.

Authors:  J J Coleman; R E Ferner; S J W Evans
Journal:  Br J Clin Pharmacol       Date:  2006-04       Impact factor: 4.335

Review 5.  Preventing adverse drug events in hospital practice: an overview.

Authors:  Mirjam K Rommers; Irene M Teepe-Twiss; Henk-Jan Guchelaar
Journal:  Pharmacoepidemiol Drug Saf       Date:  2007-10       Impact factor: 2.890

6.  Gold standards in pharmacovigilance: the use of definitive anecdotal reports of adverse drug reactions as pure gold and high-grade ore.

Authors:  Manfred Hauben; Jeffrey K Aronson
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 7.  Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.

Authors:  A J Avery; C Anderson; C M Bond; H Fortnum; A Gifford; P C Hannaford; L Hazell; J Krska; A J Lee; D J McLernon; E Murphy; S Shakir; M C Watson
Journal:  Health Technol Assess       Date:  2011-05       Impact factor: 4.014

8.  Incidence of fatal adverse drug reactions: a population based study.

Authors:  Karin Wester; Anna K Jönsson; Olav Spigset; Henrik Druid; Staffan Hägg
Journal:  Br J Clin Pharmacol       Date:  2007-12-07       Impact factor: 4.335

9.  Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients.

Authors:  Munir Pirmohamed; Sally James; Shaun Meakin; Chris Green; Andrew K Scott; Thomas J Walley; Keith Farrar; B Kevin Park; Alasdair M Breckenridge
Journal:  BMJ       Date:  2004-07-03

10.  Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes.

Authors:  Emma C Davies; Christopher F Green; Stephen Taylor; Paula R Williamson; David R Mottram; Munir Pirmohamed
Journal:  PLoS One       Date:  2009-02-11       Impact factor: 3.240
View more
  33 in total

1.  A Comparative Safety Analysis of Medicines Based on the UK Pharmacovigilance and General Practice Prescribing Data in England.

Authors:  Kinan Mokbel; Rob Daniels; Michael N Weedon; Leigh Jackson
Journal:  In Vivo       Date:  2022 Mar-Apr       Impact factor: 2.155

2.  A Comparative Analysis of Public Hospital Pharmacy Systems in Norway and Pakistan: A Pilot Implementation of the American Society of Health-System Pharmacists' (ASHP) Guidelines.

Authors:  Bilal Hasan Hashmi; Adnan Kisa
Journal:  Int J Environ Res Public Health       Date:  2022-06-27       Impact factor: 4.614

3.  The heterogeneous pharmacological medical biochemical network PharMeBINet.

Authors:  Cassandra Königs; Marcel Friedrichs; Theresa Dietrich
Journal:  Sci Data       Date:  2022-07-11       Impact factor: 8.501

4.  The effect of clinical pharmacists' intervention in adverse drug reaction reporting: a retrospective analysis with a 9-year interrupted time series.

Authors:  Tianwei Lan; Hua Wang; Xin Li; Hang Yin; Dan Shao; Yueyao Jiang; Qian Yu
Journal:  BMC Health Serv Res       Date:  2022-07-19       Impact factor: 2.908

5.  Ascorbic Acid Ameliorates Cardiac and Hepatic Toxicity Induced by Azithromycin-Etoricoxib Drug Interaction.

Authors:  Reham Z Hamza; Fatima S Alaryani; Fatma Omara; Mahmoud A A Said; Sayed A Abd El-Aziz; Sawsan M El-Sheikh
Journal:  Curr Issues Mol Biol       Date:  2022-05-31       Impact factor: 2.976

6.  Implementation of a peer support intervention to promote the detection, reporting and management of adverse drug reactions in people living with HIV in Uganda: a protocol for a quasi-experimental study.

Authors:  Ronald Kiguba; Helen Byomire Ndagije; Victoria Nambasa; Cordelia Katureebe; Henry Zakumumpa; Stella Maris Nanyonga; Jacquellyn Nambi Ssanyu; Phil Tregunno; Kendal Harrison; Corinne S Merle; Marie-Eve Raguenaud; Freddy Eric Kitutu
Journal:  BMJ Open       Date:  2022-05-19       Impact factor: 3.006

7.  Preparation and Evaluation of Lipid Emulsion Containing 13 Vitamins for Injection Without Anaphylactoid Reactions.

Authors:  Min-Quan Hui; Yan-Ni Mi; Yu-Fan Ma; Tao Chen; Yong-Xiao Cao
Journal:  Int J Nanomedicine       Date:  2021-05-12

8.  Potentially inappropriate primary care prescribing in people with chronic kidney disease: a cross-sectional analysis of a large population cohort.

Authors:  Clare MacRae; Stewart Mercer; Bruce Guthrie
Journal:  Br J Gen Pract       Date:  2021-06-24       Impact factor: 6.302

9.  Pharmacogenetics of the Central Nervous System-Toxicity and Relapse Affecting the CNS in Pediatric Acute Lymphoblastic Leukemia.

Authors:  Judit C Sági; András Gézsi; Bálint Egyed; Zsuzsanna Jakab; Noémi Benedek; Andishe Attarbaschi; Stefan Köhrer; Jakub Sipek; Lucie Winkowska; Marketa Zaliova; Stavroula Anastasopoulou; Benjamin Ole Wolthers; Susanna Ranta; Csaba Szalai; Gábor T Kovács; Ágnes F Semsei; Dániel J Erdélyi
Journal:  Cancers (Basel)       Date:  2021-05-12       Impact factor: 6.639

10.  Incidence and Predictors of Severe Adverse Drug Reaction Among Patients on Antiretroviral Therapy in Tigray, Ethiopia: A Retrospective Cohort Study.

Authors:  Teferi Gebru Gebremeskel; Destalem Gebreyowhans; Hailay Abrha Gesesew; Paul R Ward
Journal:  HIV AIDS (Auckl)       Date:  2021-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.